Paper Details

  1. Home
  2. Paper Details

[Chronic hepatitis treated with alpha-interferon].

Author: MichaelM

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
English AbstractA summary of a research paper/publication written in English for a wider audience.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

A study reviewed the effectiveness of interferon treatment for chronic viral hepatitis. In chronic hepatitis B, approximately 35% of patients showed good response to treatment, while in chronic hepatitis C, 80% responded well, though relapse was common after stopping treatment. The study also noted that further research is needed on interferon treatment for hepatitis Delta. The optimal duration of interferon treatment for chronic viral hepatitis remains an open question.
Paper Details　
Original Abstract of the Article :
The newest results on the interferon treatment of chronic viral hepatitis on the ground of controlled trials are reported. In chronic type B hepatitis about 35 percent of patients, while in chronic type C hepatitis 80 percent of patients showed good response, though in the latter disease relapse is ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/1630805

データ提供：米国国立医学図書館（NLM）

Interferon Therapy: A New Oasis in the Desert of Chronic Hepatitis

In the vast desert of infectious diseases, we are constantly seeking new and effective ways to combat these challenging conditions. This research explores the use of interferon therapy for chronic viral hepatitis, a persistent and potentially serious liver disease. The researchers investigated the effectiveness of interferon treatment in patients with chronic hepatitis B and C. The results highlight the significant efficacy of interferon in treating chronic hepatitis, particularly in patients with hepatitis C, where it demonstrated high response rates. However, the study also notes the frequent occurrence of relapse following the cessation of treatment, emphasizing the need for further research to develop more sustainable treatment strategies.

A Promising Dawn: Interferon Therapy in the Treatment of Chronic Hepatitis

This research sheds light on the potential of interferon therapy in managing chronic viral hepatitis. The findings suggest that interferon can be an effective treatment option, particularly for hepatitis C, but also highlight the need for further research to address the challenge of relapse following treatment cessation.

Navigating the Desert of Hepatitis: Understanding Interferon Therapy

For those navigating the challenging terrain of chronic hepatitis, understanding treatment options is essential. This research provides valuable insights into the potential of interferon therapy in managing this condition, emphasizing the need for ongoing research to develop more sustainable and effective treatment strategies.

Dr. Camel's Conclusion

This research reminds us that in the vast desert of infectious diseases, we must continuously explore new and innovative approaches to treatment. Just as a camel adapts to its environment, we must continue to advance our understanding of these complex conditions to develop more effective therapies and improve the lives of those affected.

Date :
  1. Date Completed 1992-08-20
  2. Date Revised 2009-10-21
Further Info :

Pubmed ID

1630805

DOI: Digital Object Identifier

1630805

SNS
PICO Info
in preparation
Languages

Hungarian

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.